GNTA
Genenta Science (GNTA)
$63
About Genenta Science (GNTA)
Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its platform and carries an interferon-alpha payload. The company was founded by Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner on July 24, 2014 and is headquartered in Milan, Italy.
Details
Daily high
$0.66
Daily low
$0.61
Price at open
$0.66
52 Week High
$10.00
52 Week Low
$0.59
Market cap
15.0M
Dividend yield
0.00%
Volume
53,682
Avg. volume
50,199
P/E ratio
-1.72
Genenta Science News
Details
Daily high
$0.66
Daily low
$0.61
Price at open
$0.66
52 Week High
$10.00
52 Week Low
$0.59
Market cap
15.0M
Dividend yield
0.00%
Volume
53,682
Avg. volume
50,199
P/E ratio
-1.72